TuesdayApr 02, 2019 10:11 am

Synthetic Cannabinoids: The Good, the Bad, and the Ugly

Today there are many cannabis-based products available, from whole-plant formulations, available at medical dispensaries, to completely man-made synthetic drugs that are FDA approved. Some of these synthetic cannabinoids mimic classic cannabinoids like THC, while others simply activate and modulate the endocannabinoid system in their own unique way, producing somewhat similar benefits to the cannabis plant. However, there exists a darker side to these synthetic cannabinoids that carry risks far greater than the cannabis plant could ever pose, and it is important to understand the differences. The Good, the Bad & the Ugly – Exploring the Light & Dark Side of Synthetic Cannabis:…

Continue Reading

MondayApr 01, 2019 1:27 pm

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Readies Online Sales Strategy for New InterceptCS Cold Sore Prevention Device

THRBF offers an IoT- and Bluetooth-enabled device for cold-sore prevention Its sales strategy is part of the company’s larger focus on developing products for the dermatology market THRBF’s proprietary technology is designed to prevent cold sores in the OTC sector, which is projected to record significant sales growth Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) is offering a new generation of technology in the burgeoning skin care market. The company is specifically planning to target sales growth for its high gross-margin InterceptCS* cold sore prevention device with a new website, social media campaign and online sales strategy (http://cnw.fm/7Ahvq). THRBF’s new InterceptCS…

Continue Reading

MondayApr 01, 2019 12:58 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Launches Its Largest Cannabinoid Research Program

The R&D program will focus on the proprietary Lexaria DehydraTECH delivery technology with the purpose of enhancing it further Results could contribute to new patent filings in the future; in addition, the program will examine more extensively the way DehydraTECH-enabled CBD outperforms generic CBD Lexaria-designed nanotech enhancements will also be included in the program Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is launching its largest cannabinoid research and development program to date. The program consists of 11 separate animal studies, according to a company press release (http://cnw.fm/YZd5X). The Lexaria in vitro study design was…

Continue Reading

MondayApr 01, 2019 12:25 pm

Marijuana Company of America Inc. (MCOA) Realizing Dream of Farm-to-Consumer Verticals in Cannabis Industry

Marijuana Company of America Inc. recently initiated a new push into tetrahydrocannabinol (THC) product development through an LOI with Natural Plant Extract of California Analysts predict that California’s cannabis market will reach $5.1 billion in sales this year and $7.7 billion by 2022 Recreational use marijuana is expected to be the prime driver in the market During a crucial year for expansion in California’s cannabis market, Marijuana Company of America Inc. (OTCQB: MCOA) is lighting the pathway toward achieving its goal of farm-to-consumer vertical collaboration among its subsidiaries in the cannabis space. MCOA recently uplisted its trading tier to the…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722